Synthetic peptides are promising therapeutic candidates for Covid-19

According to GlobalData’s Pharma Intelligence Center Pipeline Drugs Database, there are 21 peptide drugs in development for the treatment of COVID-19, including 15 synthetic peptides in development for the treatment of Acute Respiratory Distress Syndrome (ARDS) and other respiratory illnesses caused by SARS-Cov-2 infection. Five synthetic peptides candidates are already being tested in patients with COVID-19: four candidates in Phase II and one in Phase I.



About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2020 MolecularCloud